Several studies have demonstrated both plasma membrane and endoplasmic reticulum (ER) membrane TRPM8 expression, in prostate cancer cell lines that are androgen-sensitive, such as LNCaP cells (Lymph Node Carcinoma of the Prostate) [20,21]. The gene discussed is TRPM8; the disease is prostate carcinoma.